12:00 AM
 | 
Mar 12, 2012
 |  BioCentury  |  Emerging Company Profile

Transparency: Tapping the crowd

Transparency using crowdsourcing, telemedicine for clinical trials; MS is first

Transparency Life Sciences LLC is aiming to run better, cheaper clinical trials by tapping into the collaborative intelligence of stakeholders to design its studies and using telemedicine to capture data and improve enrollment.

While the company ultimately plans to in-license or acquire new compounds, it initially is repurposing generics to see if the approach can work, beginning in multiple sclerosis.

CEO and co-founder Tomasz Sablinski said most clinical trials are designed with the help of a handful of key opinion leaders. Transparency thinks that by getting more stakeholders involved in the process - such as patients, patient advocacy groups and medical students - it will be able to design better trials.

COO and co-founder Marc Foster said getting patient input on endpoints is most important because they are the most familiar with the disease.

"FDA is under enormous pressure to bring more drugs to market and to make the process more patient-centric," he added.

To this end, the company has developed a web platform for "crowdsourcing," through...

Read the full 818 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >